Rocket Lab Corp’s recently made public that its Officer FRANK KLEIN acquired Company’s shares for reported $6.98 million on Jan 02 ’26. In the deal valued at $69.76 per share,100,000 shares were bought.
Then, Frank Edward H. sold 2,500 shares, generating $193,472 in total proceeds. Upon selling the shares at $77.39, the Director now owns 142,504 shares.
Before that, Armagno Nina sold 27,314 shares. Rocket Lab Corp shares valued at $1,862,972 were divested by the Director at a price of $68.21 per share. As a result of the transaction, Armagno Nina now holds 108,940 shares, worth roughly $8.28 million.
Needham reiterated its Rocket Lab Corp [RKLB] rating to a Buy in a research note published on November 12, 2025; the price target was $63. A number of analysts have revised their coverage, including Robert W. Baird’s analysts, who began to cover the stock in mid October with a ‘”an Outperform”‘ rating. Craig Hallum began covering RKLB with “Hold” recommendation on July 28, 2025.
Price Performance Review of RKLB
On Friday, Rocket Lab Corp [NASDAQ:RKLB] saw its stock jump 8.93% to $75.99. Over the last five days, the stock has lost -1.54%. Rocket Lab Corp shares have risen nearly 188.72% since the year began. Nevertheless, the stocks have risen 8.93% over the past one year. While a 52-week high of $79.83 was reached on 01/02/26, a 52-week low of $14.71 was recorded on 01/02/26.
Levels Of Support And Resistance For RKLB Stock
The 24-hour chart illustrates a support level at 69.81, which if violated will result in even more drops to 63.64. On the upside, there is a resistance level at 79.20. A further resistance level may holdings at 82.42.
How much short interest is there in Rocket Lab Corp?
A steep rise in short interest was recorded in Rocket Lab Corp stocks on 2025-12-15, dropping by -4.54 million shares to a total of 41.21 million shares. Yahoo Finance data shows the prior-month short interest on 2025-11-14 was 45.75 million shares. There was a decline of -11.01%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on April 25, 2025 when Needham began covering the stock and recommended ‘”a Buy”‘ rating along with a $28 price target.
